What light have resting state fMRI studies shed on cognition and mood in Parkinson's disease?

Journal of Clinical Movement Disorders
Sophie YorkWilliams, Kathleen L Poston

Abstract

Much remains unknown about non-motor symptoms of Parkinson's disease (PD), which have variable occurrence, progression, and severity among patients. The existing suite of neuroimaging tools has yielded insight that cannot be garnered by traditional methods such as behavioral and post-mortem assessment. They provide information on brain activity and structure that is invaluable to understanding abnormalities associated with neurodegeneration in PD. Among these tools, functional magnetic resonance imaging (fMRI) is often favored for its safety and spatial resolution. Resting state fMRI research capitalizes on the wealth of information that the brain offers when a person is not performing a motor or cognitive task. It is also a good means to study impaired and heterogeneous populations, such as people with PD. The present article reviews research that applies resting state fMRI to the ongoing hunt for biomarkers of PD non-motor symptoms. Thus far, research in this subfield has focused on two of the most common and significant non-motor symptoms: cognitive impairment and depression. These studies support resting state fMRI as a valid and practical tool for the study of these symptoms, but discrepancies among findings highlight the ...Continue Reading

References

Oct 1, 1995·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·B BiswalJ S Hyde
Jul 3, 1998·Acta Neuropathologica·P M MattilaJ O Rinne
Sep 11, 1999·Neuron·E Wojciulik, N Kanwisher
Feb 24, 2001·Proceedings of the National Academy of Sciences of the United States of America·M E RaichleG L Shulman
Dec 11, 2002·Neurology·G LevyK Marder
Dec 31, 2002·Proceedings of the National Academy of Sciences of the United States of America·Michael D GreiciusVinod Menon
Mar 14, 2003·Archives of Neurology·Dag AarslandPer Kragh-Sørensen
May 6, 2003·Journal of Cognitive Neuroscience·Kristen A McKiernanJeffrey R Binder
Apr 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Michael D GreiciusVinod Menon
Apr 28, 2004·NeuroImage·Yufeng ZangLixia Tian
Oct 14, 2004·Journal of Neural Transmission·J L W BosboomE Ch Wolters
Nov 20, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Mariese A HelyRobert Trafficante
Mar 8, 2005·Neuron·Helen S MaybergSidney H Kennedy
Jun 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Michael D FoxMarcus E Raichle
Aug 10, 2005·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Christian F BeckmannStephen M Smith
Oct 21, 2005·Neurology·I G McKeithUNKNOWN Consortium on DLB
Feb 21, 2006·Lancet Neurology·K Ray ChaudhuriUNKNOWN National Institute for Clinical Excellence
Jun 17, 2006·Annual Review of Neuroscience·Marcus E Raichle, Mark A Mintun
Mar 3, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·William W SeeleyMichael D Greicius
Mar 3, 2007·The American Journal of Psychiatry·Abigail G GarrityVince D Calhoun
Jun 2, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Murat EmreBruno Dubois
Jun 29, 2007·Human Brain Mapping·Paul B FitzgeraldZafiris J Daskalakis
Aug 21, 2007·Nature Reviews. Neuroscience·Michael D Fox, Marcus E Raichle
Mar 1, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Mariese A HelyJohn G L Morris
Mar 18, 2008·Journal of Neurology, Neurosurgery, and Psychiatry·J Jankovic
Jul 24, 2008·Human Brain Mapping·Tao WuPiu Chan
Oct 1, 2008·Neuroscience and Biobehavioral Reviews·Samantha J BroydEdmund J S Sonuga-Barke
Apr 21, 2009·Neuron·William W SeeleyMichael D Greicius
Jul 11, 2009·The Neurologist·Amy C AlmarazDean M Wingerchuk
Sep 29, 2009·NeuroImage·Xi-Nian ZuoMichael P Milham
Oct 9, 2009·Alzheimer Disease and Associated Disorders·Marwan N SabbaghThomas G Beach
Oct 9, 2009·Alzheimer Disease and Associated Disorders·Marwan N SabbaghThomas G Beach
Oct 13, 2009·NeuroImage·Mikail Rubinov, Olaf Sporns
Jan 9, 2010·Nature Reviews. Neurology·Dongyang Zhang, Marcus E Raichle
May 25, 2010·Trends in Cognitive Sciences·Steven L Bressler, Vinod Menon
Jun 11, 2010·Proceedings of the National Academy of Sciences of the United States of America·Yvette I ShelineMark A Mintun
Jan 6, 2011·Frontiers in Systems Neuroscience·Youngbin KwakRachael D Seidler
Jan 21, 2011·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Simone GrimmGeorg Northoff
May 3, 2011·Biological Psychiatry·Roshan Cools, Mark D'Esposito

❮ Previous
Next ❯

Citations

Jul 14, 2017·Journal of Neural Transmission·Joseph ClassenAlexander Storch
Oct 27, 2017·Brain Connectivity·Raíssa Benocci ThibesJoão Ricardo Sato

❮ Previous
Next ❯

Software Mentioned

ICA
ALFF
ReHo
MELODIC
FSL

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Neurology and Neuroscience Reports
Janey ProdoehlDavid E Vaillancourt
International Review of Neurobiology
Rosa De MiccoAlessandro Tessitore
Journal of the American Geriatrics Society
Daniel WeintraubMatthew B Stern
© 2022 Meta ULC. All rights reserved